CCL2 and COVID-19: In addition to a suggestive association between CCL2-A2518G gene variants and the severity of COVID-19 [145], a genome-wide study showed associations between the risk of severe COVID-19 and a multigene locus at 3p21.31 and the ABO blood group locus at 9q34.2.